Scientists Develop Hedge Hyssop Extract for Advanced Cancer Treatment
Sputnik – 19.10.2023
Scientists from Razumovsky University – or, to give it its full name Saratov State Medical University Named After VI Razumovsky (SSMU) – have developed an innovative anti-tumor herbal medicinal product based on the gratiola officinalis, a plant commonly known as medicinal hedge hyssop.
Fundamental research has been continuing for more than a decade, and according to the researchers, it has yielded compelling results. Based on these findings, the university has received approval from the Russian Ministry of Health to conduct Phase I clinical trials.
Medicinal Hedge Hyssop (gratiola officinalis) is a wild, perennial herb widely distributed in various regions of Russia. Although it possesses toxic properties, it has been used in traditional medicine in the form of infusions, known as the “Zdrenko mixture”.
Alexander Fedonnikov, SSMU’s Vice-Rector for Science and Innovations, told Sputnik that this new hedge hyssop-based drug has no direct analogue in global pharmacopeia. He clarified that existing drugs on the market, known as cytostatic drugs, cause massive destruction of tumor cells, often accompanied by severe toxicity to the body.
However, SSMU scientists claim that their innovative herbal treatment, based on hedge hyssop, activates apoptosis – programmed cell death that occurs under normal conditions in the body’s functioning.
“According to the results of pre-clinical studies, this drug produces significantly fewer side effects and is better tolerated by the body,” Fedonnikov emphasized.
He also said that the developed extract is a candidate for the position of the world’s first-class plant-based anti-tumor medication. According to his assessment, industrial production and clinical application of this drug could become a cutting-edge import substitution technology in cancer treatment.
The process of hedge hyssop extraction was developed by scientists from the Research Institute of Fundamental and Clinical Uronephrology of the Department of Pathological Anatomy, and the Faculty of Pharmacy.
“A complex recipe was selected: the herb was mixed with alcohol, dissolved in water, chloroform, and so on. By comparing different extract fractions, we selected the most active one. This is how we obtained a phytopreparation from components with the highest biological activity,” explained Professor Natalia Polukonova.
She noted that during pre-clinical research, safety data for the drug were obtained for various types of laboratory animals, and the potential efficacy of the phytopreparation was proved.
“Our experiments on laboratory animals showed that one month of taking the obtained extract reduces the tumor’s growth rate by 70 percent. These are very promising numbers. A drug is considered potentially effective if it slows tumor development by at least 30 percent,” she added.
The university reported that the research was conducted on 10 different cancer cell lines, including kidney cancer, bladder cancer, sarcoma, liver cancer, ovarian cancer and breast cancer. Based on the results, the university obtained approval from the Russian Ministry of Health to conduct a Phase I clinical trial. It is expected that cancer patients in the late stages of the disease will participate in this trial.
“These individuals will receive comprehensive treatment, and the developed drug is planned to be prescribed as an addition to it,” SSMU explained, pointing out that in this regard, scientists are guided by global ethical practices. New anti-tumor drugs are typically first applied to patients in the advanced stages of the disease. The clinical trials will be conducted at the Mirotvortsev University Clinical Hospital No 1.
According to Saratov scientists, the availability of an extensive raw material base for collecting wild medicinal hedge hyssop, combined with the already established production technology, ensures 100 percent localization of the entire production cycle in Russia, from plant collection to the finished medicinal form.
“Medicinal plants are not just promising; they have long been a part of our medical aid kits, and they work. The successful completion of this clinical trial will allow us to proceed to further phases of research to evaluate its effectiveness and, after a series of clinical trials, complete the process of state registration,” the university’s deputy director noted. He added that with this development, the university has become a part of the Russian Ministry of Health’s federal project “Medical Science for Humanity”.
Share this:
Related
October 19, 2023 - Posted by aletho | Science and Pseudo-Science, Timeless or most popular | Russia
No comments yet.
Featured Video
US Congress Behind Closed Doors – Using Ukrainians to Weaken Russia
or go to
Aletho News Archives – Video-Images
From the Archives
Some Call It Conspiracy Theory – Part 1
BY IAIN DAVIS | SEPTEMBER 25, 2023
There are certain assumptions that are applied to anyone labelled a “conspiracy theorist”—and all of them are fallacies. Indeed, the term “conspiracy theory” is nothing more than a propaganda construct designed to silence debate and censor opinion on a range of subjects. Most particularly, it is used as a pejorative to marginalise and discredit whoever challenge the pronouncements and edicts of the State and of the Establishment—that is, the public and private entities that control the State and that profit from the State.
Those of us who have legitimate criticisms of government and its institutions and representatives, who are therefore labelled “conspiracy theorists,” face a dilemma. We can embrace the term and attempt to redefine it or we can reject it outright. Either way, it is evident that the people who weaponise the “conspiracy theory” label will continue to use it as long as it serves their propaganda purposes.
One of the most insidious aspects of the “conspiracy theory” fabrication is that the falsehoods associated with the term have been successfully seeded into the public’s consciousness. Often, propagandists need do no more than slap this label on the targeted opinion and the audience will immediately dismiss that viewpoint as a “lunatic conspiracy theory.” Sadly, this knee-jerk reaction is usually made absent any consideration or even familiarity with the evidence presented by that so-called “lunatic conspiracy theorist.”
This was the reason why “conspiracy theorist” label was created. The State and its propagandists do not want the public to even be aware of inconvenient evidence, let alone to examine it. The challenging evidence is buried under the “wild conspiracy theory” label, thereby signalling to the unsuspecting public that they should automatically reject all of the offered facts and evidence.
There are a number of components that collectively form the conspiracy theory canard. Let’s break them down. … continue
Blog Roll
-
Join 2,369 other subscribers
Visits Since December 2009
- 7,832,261 hits
Looking for something?
Archives
Calendar
Categories
Aletho News Civil Liberties Corruption Deception Economics Environmentalism Ethnic Cleansing, Racism, Zionism Fake News False Flag Terrorism Full Spectrum Dominance Illegal Occupation Mainstream Media, Warmongering Malthusian Ideology, Phony Scarcity Militarism Progressive Hypocrite Russophobia Science and Pseudo-Science Solidarity and Activism Subjugation - Torture Supremacism, Social Darwinism Timeless or most popular Video War Crimes Wars for IsraelTags
Afghanistan Africa AIPAC al-Qaeda Australia BBC Benjamin Netanyahu Brazil Canada CDC Central Intelligence Agency China CIA CNN Covid-19 COVID-19 Vaccine Donald Trump Egypt European Union Facebook FBI FDA France Gaza Germany Google Hamas Hebron Hezbollah Hillary Clinton Human rights Hungary India Iran Iraq ISIS Israel Israeli settlement Japan Jerusalem Joe Biden Korea Latin America Lebanon Libya Middle East National Security Agency NATO New York Times North Korea NSA Obama Pakistan Palestine Poland Qatar Russia Sanctions against Iran Saudi Arabia Syria The Guardian Turkiye Twitter UAE UK Ukraine United Nations United States USA Venezuela Washington Post West Bank WHO Yemen Zionism
Aletho News- Trump’s Cyber Director Pick Has Deep Ties To Israeli Intelligence
- Get ready for the big Israeli false flag cyber-attack
- The Ukrainian Reset experiment: A war and surveillance state blueprint for the EU
- Pentagon fails ninth financial audit in a row, unable to account for trillions in assets
- Russia rejects Danish plot claims, vows response to expulsion
- Study of 14,000 Children Links Vaccination to Higher Rates of Chronic Illness
- Strike Iran Again, Open Pandora’s Box | Brian McGlinchey
- ‘Revenge of Big Pharma’: 12 States Could Lose Religious Exemptions to Vaccination in 2027
- Brazil targeted by Western biopower
- B’nai B’rith UK’s bid to brand anti-Zionism as extremism
If Americans Knew- An error has occurred; the feed is probably down. Try again later.
No Tricks Zone- Germany’s Renewable Energies Lead to 1.4 Billion Euro Electric Power Trade Deficit
- Argentina’s Perito Moreno Glacier Joins Antarctica and Arctic In Defying Doomsday Melt Claims
- New Study: Barents Sea Temperatures Were Warmer And Sea Ice Less Extensive In The 1700s Than Today
- German Authorities Start Initiative To Evaluate Public Register For Climate “Disinformation” Spreaders!
- Zonal Asymmetry of Temperature Change in the Antarctic Circumpolar Current
- New Study: The Net Fossil Fuel Contribution To Rising Atmospheric CO2 Has Been Zero For 500 Years
- Germany’s Green Energy Transition Becoming Increasingly Expensive…Another 6 Trillion Euros!
- Sudden Stratospheric Warming, Powerful El Niño Combination May Lead To Extreme Europe Cold, Energy Crisis!
- Two New Studies Find Thwaites Glacier Melt Cannot Be Driven By Human Activity Or A Warming Ocean
- E-Cars Reduce CO2 Emissions By Only 41% Compared To Internal Combustion Engine Vehicles
Contact:
atheonews (at) gmail.com
Disclaimer
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.

Leave a Reply